Strategic design of intelligent-responsive nanogel carriers for cancer therapy

H Wang, L Gao, T Fan, C Zhang, B Zhang… - … applied materials & …, 2021 - ACS Publications
Owing to the distinctive constituents of tumor tissue from those healthy organs,
nanomedicine strategies show significant potentials in smart drug delivery. Nowadays …

How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme

M Sanati, S Aminyavari, H Mollazadeh, B Bibak… - Pharmacological …, 2022 - Springer
Since the discovery of phosphodiesterase-5 (PDE5) enzyme overexpression in the central
nervous system (CNS) malignancies, investigations have explored the potential capacity of …

[HTML][HTML] siRNA delivery mediated by pH and redox responsive p (DEAEMA-co-HEMA-g-PEGMA) nanogels

MK Notabi, EC Arnspang, NA Peppas… - Journal of Drug Delivery …, 2023 - Elsevier
Small interfering RNAs (siRNA) have enabled novel, specific, and efficient treatment of
diseases, including cancer. To obtain sufficient and well-controlled intracellular delivery, a …

[PDF][PDF] Rational design of Carbon Nanodots as potential theranostic agents in breast cancer

MA Utzeri - 2023 - tesidottorato.depositolegale.it
Carbon nanodots (CDs) have aroused increased attention as promising nanotools for drug
delivery, fluorescence imaging, and NIR-induced photothermal therapy, due to their versatile …